TY  - GEN
AU  - Du Bois,J S
AU  - Trehu,E G
AU  - Mier,J W
AU  - Shapiro,L
AU  - Epstein,M
AU  - Klempner,M
AU  - Dinarello,C
AU  - Kappler,K
AU  - Ronayne,L
AU  - Rand,W
AU  - Atkins,M B
TI  - Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma
SN  - 0732-183X
PY  - 1997///0331
KW  - Adult
KW  - Aged
KW  - Antigens, CD
KW  - Carcinoma, Renal Cell
KW  - blood
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Immunoglobulin G
KW  - adverse effects
KW  - Immunophenotyping
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Monocytes
KW  - Receptors, Tumor Necrosis Factor
KW  - Receptors, Tumor Necrosis Factor, Type II
KW  - Recombinant Fusion Proteins
KW  - Skin Neoplasms
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1997.15.3.1052
ER  -